000			01421 a2200217 4500
003			OSt
005			20251205160554.0
008			251205b |||||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_aBelhekar, Mahesh N. _927704
245			_aCase of hypersensitivity to soluble and isophane insulins but not to insulin glargine
250			_aVol.47(2), Mar-Apr
260			_aMumbai _bWolter Kluwer _c2015
300			_a227-229p.
520			_aInsulin is an important agent for the treatment of diabetes mellitus (DM). Allergic reactions to insulin therapy, although rare, have been evident since animal insulin became available for the treatment of DM in 1922. Hypersensitivity to insulin has considerably been reduced with the introduction of human insulin produced by recombinant deoxyribonucleic acid technology. Here, we present a case of Type 2 DM who demonstrated immediate (Type 1) hypersensitivity reaction on the sites of subcutaneous injection of soluble and isophane insulin but insulin glargine was tolerated well and provided good glycemic control.
650		0	_aPHARMACOLOGY _94774
700			_aPai, Sarayu _927705
773	0		_dAndheri - Mumbai Wolters Kluwer India Private Limited _tIndian Journal of Pharmacology _x0253-7613
856			_uhttps://journals.lww.com/iphr/fulltext/2015/47020/a_case_of_hypersensitivity_to_soluble_and_isophane.22.aspx _yClick here
942			_2ddc _cAR
999			_c23744 _d23744